FdaApplication
NDA 210660
Identifiers
- fda_app_no: NDA210660
Properties
| Property | Value |
|---|---|
| applicant_name | EXELA PHARMA SCIENCES LLC |
| application_type | NDA |
| approval_date | 2019-04-16 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ELCYS | CYSTEINE HYDROCHLORIDE | 2500MG/50ML (50MG/ML) | SOLUTION;INTRAVENOUS |
| ELCYS | CYSTEINE HYDROCHLORIDE | 500MG/10ML (50MG/ML) | SOLUTION;INTRAVENOUS |
2 products